LockDown traces its roots back to the 1920s and has historically focused on spinal surgeries and implants. With a rich history of product development and innovation, the company has experienced a paradigm shift in its focus over the last 15 years and now concentrates on developing innovative soft tissue reconstruction devices. Thousands of LockDown ACJ reconstruction devices have been implanted all over the world. The company’s core product—LockDown Shoulder Stabilization System (LSSSTM)—enables surgeons to achieve effective results along with helping patients get back to active service, manual labor, or full contact sports as quickly and efficiently as possible.
LSSSTM is a simple and elegant solution for ACJ dislocations, which includes a synthetic braid that wraps around the coracoid—a part of the scapula or the shoulder bone—and passes around the posterior of the clavicle. The braid is then secured using a single screw of 3.5 mm diameter positioned on the anterior surface of the clavicle and running in the anterior-posterior direction. This provides strength and stability while also allowing natural rotation of the clavicle.
A major contributing factor to LockDown’s success is the collaborative approach that the company adopts in developing solutions and techniques. In fact, the company’s ACJ device and technique were developed in alliance with a renowned surgeon from Nottingham. “We are always looking forward to collaborating with leading surgeons and devising strategies to develop their ideas into techniques that can be applied in the market,” states Burns. The company also plans to further explore the application of its implantable devices in other areas of ligament reconstruction and beyond.
Outside the UK, LockDown has a subsidiary in the US along with a significant presence in the markets of Australia, New Zealand, and Korea. The company has recently registered its product for sale in Malaysia and is looking for new distributors to expand its reach in the APAC region.